GCL
STJ

Glazer Capital LLC’s St Jude Medical STJ Stock Holding History

Glazer Capital LLC’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-821,235
Closed -$65.9M – 103
2016
Q4 		$65.9M Buy
+821,235
New +$65.2M 11.93% 3
2016
Q3 		– Sell
-222,000
Closed -$17.3M – 97
2016
Q2 		$17.3M Buy
+222,000
New +$15.8M 2.23% 16

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Glazer Capital LLC's STJ Position: Q1 2017 in Review

Glazer Capital LLC sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 821,235 shares — an estimated $65.9M sold.

Glazer Capital LLC first reported a position in STJ in Q2 2016 and held it in 2 quarters. The position peaked at $65.9M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Glazer Capital LLC reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Glazer Capital LLC sold 821,235 St Jude Medical shares in Q1 2017, an estimated $65.9M.
  • Glazer Capital LLC first reported a position in St Jude Medical in Q2 2016 and held it in 2 quarters.
  • Glazer Capital LLC's St Jude Medical position peaked at $65.9M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Glazer Capital LLC's 13F filing for Q1 2017, filed 15 May 2017.